Compared to JAK2V617F-mutated ET, CALR-mutated ET patients also tended to have high levels of TGF-β1 and IL-33, but differences were not significant (p = 0.070 and p = 0.065, respectively; Mann–Whitney t-test). The gene discussed is IL33; the disease is essential thrombocythemia.